Tanya Harding, Ph.D.

Partner

tanya.harding-.-{/email/}-.-leehayes.com

T 503.317.4728

Paralegal

Brian Moffenbeier

brian.moffenbeier-.-{/email/}-.-leehayes.com

T 503.706.3121

Education

Cornell University
Juris Doctor, cum laude

University of California, Davis
Doctor of Philosophy, Plant Biology

Rutgers University, Cook College
Bachelor of Science in Biotechnology specializing in plants, magna cum laude

Associations

Admitted to practice law in the state of Oregon

Registered to practice before the U.S. Patent and Trademark Office

Patents

U.S. Patent No. 9,700,578 “Use of Nitrite Salts for the Treatment of Cardiovascular Conditions”
U.S. Patent No. 9,447,429 “Method to Trigger RNA Interference”
U.S. Patent No. 9,115,400 “LMNA Gene and Its Involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and Arteriosclerosis”
U.S. Patent No. 9,040,248 “Kits for Detecting and Monitoring Endocrine Disrupting Chemicals (EDCS)”
U.S. Patent No. 8,865,672 “Prevention of Tissue Ischemia and Related Methods”
U.S. Patent No. 8,835,378 “Multi-Domain Amphipathic Helical Peptides and Methods of Their Use”
U.S. Patent No. 8,828,356 “Farnesyltransferase Inhibitors for Treatment of Laminopathies, Cellular Aging and Atherosclerosis”
U.S. Patent No. 8,420,099 “Chimeric Protein for Prevention and Treatment of HIV Infection”
U.S. Patent No. 8,263,075 “Antibody Molecule for Human GM-CSF Receptor Alpha”
U.S. Patent No. 8,202,969 “Platelet Derived Growth Factor Receptor Alpha (PDGFRA) Polypeptides Comprising Activating Mutation(s)
European Patent No. 1 648 475 “Use of Nitrite Salts for the Treatment of Cardiovascular Conditions”

Tanya has more than two decades of experience preparing and prosecuting U.S., international, and foreign patent applications, as well as advising clients with regard to patent-related administrative proceedings, including post-grant proceedings, European third-party document submissions, and European oppositions. She has also prepared legal opinions, including patentability, inventorship, freedom to use, and infringement/non-infringement opinions. Client counseling regarding intellectual property (IP) portfolio management, portfolio acquisition/transfer, and due diligence are additional aspects of Tanya’s work.

Tanya has experience patenting technologies in areas including molecular and cell biology, basic and applied plant biology, genetics (of plants, animals, and microbes), biofuel production, cancer and immunology, vaccines, infectious diseases (including bacterial, fungal, and viral diseases) of animals and plants, inherited diseases (including diagnostic methods and compositions, as well as personalized treatments), CRISPR and other genetic editing systems, biomedical informatics, nanoparticles (including for delivery of therapeutics), and microarray and high throughput technologies.

Prior to joining Lee & Hayes, Tanya was a partner at an internationally-recognized IP law firm. Before she obtained her law degree, Tanya earned her Ph.D. in Plant Biology. Her doctoral research focused on non-canonical intracellular protein trafficking, particularly from the cytoplasm to the vacuole, in yeast cells.